文献速递细胞病理与分子病理乳腺病理

液基细胞学专属队列中乳腺FNAB横滨系统观察者间一致性与恶性风险

Interobserver agreement and risk of malignancy using the International Academy of Cytology Yokohama System for reporting breast FNA biopsy in a liquid-based exclusive cohort.
PubMed 文献 · Cancer Cytopathol · 2024-02-27

研究纳入2017年1月至2021年1月仅以液基细胞学(全部为ThinPrep)提交的乳腺细针穿刺活检(FNAB)标本110例,由1名细胞学家和6名细胞病理学家按国际细胞学会横滨系统(YS)盲法判读,计算观察者间一致性与恶性风险。结果显示各判读员与随访组织病理学之间一致性为实质至近乎完全一致,不足与不典型两类一致性最低,恶性风险在不典型、可疑恶性与恶性类别中较高。

要点

  • 液基细胞学标本按YS五分类判读的观察者间一致性优良(κ=0.73-0.91)。
  • 不足与不典型类别一致性最低(κ分别为0.05与0.04),是判读难点。
  • 不典型类别恶性风险为67%(8/12),提示需结合细胞量与结构特征谨慎判读。

核心结论

  • 在液基细胞学乳腺FNAB中使用YS五分类判读的观察者间一致性优良。
  • 细胞量不足与结构特征不完整是阻碍完全一致的障碍。
  • 液基细胞学判读中的已知陷阱是不典型诊断的原因。

研究设计与样本

  • 回顾性纳入2017年1月至2021年1月仅以液基细胞学(全部为ThinPrep)提交的乳腺FNAB标本,排除无组织病理学随访的病例。
  • 由1名细胞学家和6名细胞病理学家按YS判读,所有判读者对原始诊断和组织病理学随访设盲,共复习110例。

主要发现

  • 各判读员与随访组织病理学之间的一致性为κ=0.73-0.91。
  • 各判读员与随访组织病理学之间的一致性为κ=0.66-0.85。
  • 不足类别一致性κ=0.05,不典型类别一致性κ=0.04,为最低。
  • 不典型类别缺乏一致性常见于细胞量低或结构特征不完整的病例。

关键数值与推荐

  • 恶性风险:不足12.5%(2/16)、良性3%(2/65)、不典型67%(8/12)、可疑恶性100%(1/1)、恶性100%(16/16)。

临床怎么用

  • 建议持续培训与教育,以因应液基细胞学非传统细胞形态特征避免误诊,并改善YS中不足与不典型类别的比例。

局限性

  • 原文未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Per the College of American Pathologist's National Breast Fine Needle Aspiration Biopsy (FNAB) Practice Survey, ∼40% of laboratories use liquid-based cytology (LBC) for breast FNAB. The reproducibility of the International Academy of Cytology Yokohama System (YS) for reporting breast FNAB on LBC was explored. DESIGN: Breast FNAB specimens submitted as LBC only (all ThinPrep) between January 2017 and January 2021 were retrieved. Cases without histopathologic follow-up were excluded. Clinical and radiologic information was collected. One cytologist and six cytopathologists rendered diagnoses per YS. All reviewers were blinded to the original diagnosis and histopathologic follow-up. The risk of malignancy was calculated. Concordance rates were calculated by a weighted Cohen Kappa score (κ). RESULTS: Review of 110 cases demonstrated substantial to near-perfect agreement between each reviewer (κ = 0.73-0.91) and follow-up histopathology (κ = 0.66-0.85). The agreement was lowest in the inadequate (κ = 0.05) and atypical (κ = 0.04) categories. The lack of concordance in the atypical category was common in cases with low cellularity or incomplete structural features. The risk of malignancy for inadequate, benign, atypical, suspicious for malignancy, and malignant categories were 12.5% (2/16), 3% (2/65), 67%, (8/12) 100% (1/1), and 100% (16/16). CONCLUSION: Interobserver agreement is excellent using the five YS categories in LBC. Lack of cellularity and incomplete architectural features were barriers to perfect agreement. Established pitfalls in the interpretation of LBC were cause for atypical diagnoses. Continuous training and education are recommended to avoid misdiagnosis because of the nonconventional cytomorphologic features of LBC and to improve inadequate and atypical rates within YS.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Folarin O, Kim D, Gokozan HN, et al. Interobserver agreement and risk of malignancy using the International Academy of Cytology Yokohama System for reporting breast FNA biopsy in a liquid-based exclusive cohort. Cancer Cytopathol. 2024. PMID: 38410851. doi:10.1002/cncy.22798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。